Viewing Study NCT01694758


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT01694758
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2012-09-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module